Filing Details
- Accession Number:
- 0001562180-25-000221
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-06 19:30:59
- Reporting Period:
- 2025-01-02
- Accepted Time:
- 2025-01-06 19:30:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1831363 | Terns Pharmaceuticals Inc. | TERN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1892413 | Emil Kuriakose | C/O Terns Pharmaceuticals, Inc. 1065 E. Hillsdale Blvd., Suite 100 Foster City CA 94404 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-01-02 | 4,481 | $5.71 | 54,269 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents shares of common stock sold to satisfy taxes associated with the vesting of a restricted stock unit award previously granted to the Reporting Person. Such sales do not represent a discretionary trade by the Reporting Person.
- This sale price represents the weighted average sale price of the shares sold ranging from $5.65 to $5.80 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
